SCIEX · 5 months ago
Vice President, Research and Development
Aldevron, a Danaher operating company, is dedicated to advancing life sciences and biotechnology. They are seeking a Vice President of Research and Development to establish research priorities, mentor R&D teams, and interface with clients to drive innovation and achieve strategic goals.
BiotechnologyManufacturingMedical DeviceProduct Design
Responsibilities
Establish research priorities, resourcing, and scientific outcomes to achieve the company’s strategic goals and objectives
Provide the scientific background knowledge needed to make important decisions and develop future strategic plans
Supervise key discovery experiments and development processes to advance the company’s pipeline programs towards development milestones
Mentor and develop direct R&D reports, contributing to the company’s IP portfolio for its R&D pipeline
Serve as the technical leader on core product/process initiatives to ensure new products and processes are developed to keep Aldevron leading the industry
Develop and lead a high-performing scientific and technical cross-functional team of R&D
Interface directly with clients to establish client-specific product and process requirements and grow new business opportunities
Qualification
Required
12+ years of experience in biochemical research or related area
Track record of leading research collaborations with academia and industry
Experience leading teams, including direct supervision of researchers
Doctoral degree (Ph.D.) in a scientific discipline related to Aldevron's core business (Biology, Biochemistry, Genetics, Chemistry, etc.) and/or a Doctor of Medicine degree (M.D.)
Preferred
Previous experience in biochemical engineering principles, scale-up, and process optimization
Cloning techniques, synthetic DNA, and RNA experience
Benefits
Comprehensive, competitive benefit programs
Health care program
Paid time off
Company
SCIEX
SCIEX is a biotechnology company that sells mass spectrometers, capillary electrophoresis, and ion sources products.
Funding
Current Stage
Late StageTotal Funding
unknown2010-02-01Acquired
Leadership Team
Recent News
2025-11-19
BioTech Breakthrough
2025-11-08
2025-11-07
Company data provided by crunchbase